Last A$0.44 AUD
Change Today +0.005 / 1.15%
Volume 16.0K
As of 11:49 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

dorsavi ltd (DVL) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/28/14 - A$0.59
52 Week Low
12/11/13 - A$0.35
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DORSAVI LTD (DVL)

Related News

No related news articles were found.

dorsavi ltd (DVL) Related Businessweek News

No Related Businessweek News Found

dorsavi ltd (DVL) Details

dorsaVi Limited, a biotechnology company, focuses on developing motion analysis device technologies. It provides wireless sensor movement monitoring systems and products, including ViPerform for the elite sports market to assist coaching and support staff for screening and managing their team list and athletes; ViSafe, an occupational health and safety products that enable employers to enhance worker safety and work efficiencies by undertaking detailed movement studies of workers in the workplace as they perform their tasks in real-time; and ViMove, which enables clinicians to measure and assess musculoskeletal conditions and the effectiveness of interventions. The company was incorporated in 2008 and is based in Melbourne, Australia.

Founded in 2008

dorsavi ltd (DVL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dorsavi ltd (DVL) Key Developments

dorsaVi Limited Announces Preliminary Financial Results for the Year Ended June 30, 2014

dorsaVi Limited announced preliminary financial results for the year ended June 30, 2014. For the year, the company reported revenue of AUD 767,000. Loss after tax was AUD 3,562,000.

dorsaVi to Commence Sale of ViMove in the US Following FDA Clearance

dorsaVi Limited will commence launch of ViMove in the United States following 510K clearance by the US Food and Drug Administration (FDA) for measuring, recording, and reporting on movement and muscle activity of the lower back /lumbar spine. ViMove consists of wearable sensors that are placed on the body to measure movement and muscle activity. Patients can be assessed through a series of movements or exercises performed in-clinic, or outside the clinic, at home or at work, where ViMove can monitor their everyday activities, and provide immediate biofeedback to the patient and a concise report for the healthcare practitioner. 510K clearance is required for certain types of medical devices before a manufacturer can introduce a device into commercial distribution for the first time in the US market.

dorsaVi Ltd. Appoints Jerome Whelan as Chief Financial Officer

dorsaVi Ltd. announced the appointment of Jerome Whelan as Chief Financial Officer. Mr. Whelan is a highly regarded, global y experienced finance executive whose areas of expertise include financial operational management, corporate accounting, financial analysis, forecasting, change management, proces redesign and new systems integration. Most recently, Mr. Whelan held the position of Australian Chief Financial Officer of SapientNitro.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVL:AU A$0.44 AUD +0.005

DVL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DVL.
View Industry Companies

Industry Analysis


Industry Average

Valuation DVL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 95.1x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 26.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DORSAVI LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at